Breaking News

You are here » Indian-Commodity  :  Top News  :  Jubilant Life Sciences' arm raises $300 million through bond issuance


Jubilant Life Sciences' arm raises $300 million through bond issuance

Jubilant Pharma (JPL), a 100% subsidiary of Jubilant Life Sciences, has successfully raised $300 million through a sale of unsecured bonds. The bonds have been subscribed at the tight end of the final price guidance offering a yield of 4.875% to investors.  The net proceeds of the Notes shall be used to prepay the existing debts of JPL and its subsidiaries, for upstreaming up to $50 million to Jubilant Life Sciences for prepayment of its existing debts and for general corporate purposes. The company received bids over $1 billion. The bonds will be listed on Singapore Stock Exchange. The issuer (JPL) has been rated BB- by- Standard & Poor's Ratings Services (S&P) and Fitch Inc (Fitch) and the issue (the notes) has been rated BB- by S&P and BB by Fitch.

Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, Allergy Therapy Products and Life Science Ingredients.

Related News

View all news

Gold futures decline on firming dollar

Gold futures declined on MCX as traders await the minutes from the US Federal Reserve's latest policy meeting for fresh clues on the pace of interest rate hikes. Besides, a firming dollar against some......

Coriander futures edge higher on improved demand

Coriander futures edged higher on NCDEX as participants built up fresh positions on the back of improved demand at the spot market. Further, tight supplies from major producing regions also fuelled the......

Gold end higher on Tuesday

Gold futures ended higher on Tuesday amid weak dollar against basket of major currencies, ahead of the release of minutes of Federal Open Market Committee's September meeting. Gold futures for December......

Top News

View all news

Hero MotoCorp achieves best ever sales performance in Q2 FY19

Hero MotoCorp has achieved its best-ever sales performance for the second quarter of any financial year, selling 21,34,051 units of two-wheelers in Q2 FY19.For the period April-September 2018, Hero MotoCorp......

Mahindra CIE Automotive reports 74% rise in Q3 net profit

Mahindra CIE Automotive has reported results for third quarter ended September 30, 2018.The company has reported 73.80% rise in its net profit at Rs 42.58 crore for the quarter under review as compared......

Infosys crosses $2 billion large deal signings in Q2 FY19

Infosys has crossed $2 billion large deal signings in Q2 FY19. Besides, the company's digital revenues stood at $905 million in Q2 FY19 (31.0% of total revenues), year-on-year growth of 33.5% and sequential......